Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Cancer Drug Pricing & Economics

Rena Conti

PhD

🏢Boston University Questrom School of Business🌐USA

Professor of Markets, Public Policy, and Law

40
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Rena Conti is a health economist at Boston University whose research has illuminated the market dynamics driving cancer drug prices, including the roles of competition, drug shortages, and the 340B drug pricing program. Her analyses of oncology drug supply chain economics and the slow adoption of biosimilars in cancer care have identified market failures in the cancer pharmaceutical sector. Her policy research has informed Congressional deliberations on drug pricing reform.

Share:

🧪Research Fields 研究领域

Oncology drug market dynamics
Drug shortage cancer impact
340B drug pricing program
Pharmaceutical supply chain cancer
Biosimilar adoption oncology

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Rena Conti 的研究动态

Follow Rena Conti's research updates

留下邮箱,当我们发布与 Rena Conti(Boston University Questrom School of Business)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment